apollo

Select Address

Search Medicines
  • Login
  1. Home
  2. Canrib 150 mg Tablet 60's

  3. Canrib 150 mg Tablet 60's Substitute

Canrib 150 mg Tablet 60's Substitute

Substitutes safety advice
call Doctor

Verified Ingredients and Effects

Composition:

OLAPARIB-150MG

Uses:

Canrib 150 mg Tablet 60's is used in the treatment of Ovarian cancer, breast cancer, pancreatic cancer, and prostate cancer. The detailed uses of Canrib 150 mg Tablet 60's are as follows:<br/>• Ovarian Cancer: Canrib 150 mg Tablet 60's helps in maintenance treatment for advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer after response to platinum-based chemotherapy and especially effective in patients with BRCA mutations or homologous recombination deficiency (HRD).<br/>• Breast Cancer: Canrib 150 mg Tablet 60's is used for HER2-negative, BRCA-mutated metastatic or high-risk early breast cancer and used after chemotherapy and sometimes endocrine therapy.<br/>• Pancreatic Cancer: Canrib 150 mg Tablet 60's helps in maintenance treatment for germline BRCA-mutated metastatic pancreatic cancer that hasn’t progressed after platinum-based chemotherapy.<br/>• Prostate Cancer: Canrib 150 mg Tablet 60's is for BRCA-mutated metastatic castration-resistant prostate cancer, often after prior hormonal therapy.<br/>

Medicinal Benefits:

Canrib 150 mg Tablet 60's belongs to a group of medicines known as 'anti-cancer' drugs used to treat various cancers, including Ovarian, breast, pancreatic, and prostate.  Canrib 150 mg Tablet 60's contains Olaparib, a targeted drug called a PARP inhibitor. PARP (polyadenosine 5’-diphosphoribose polymerase) is a protein that helps damaged cells repair themselves. Olaparib stops PARP working. Some cancer cells rely on PARP to keep their DNA healthy. So, the cancer cells die when Olaparib stops PARP from repairing DNA damage.

FAQs

Canrib 150 mg Tablet 60's is used to treat ovarian, breast, pancreatic, and prostate cancers.

Canrib 150 mg Tablet 60's contains Olaparib, a targeted drug called a PARP inhibitor. PARP is a protein that helps damaged cells to repair themselves. Olaparib stops PARP working. Some cancer cells rely on PARP to keep their DNA healthy. So, the cancer cells die when Olaparib stops PARP from repairing DNA damage.

If you are allergic to Olaparib or any other ingredients in this medication, are breastfeeding, or have too low blood cell counts, you should not use Canrib 150 mg Tablet 60's.

Yes, Canrib 150 mg Tablet 60's can cause low neutrophils levels, a type of white blood cells that help fight infections. If your white blood cells become low, you can be at higher risk for infections. Tell your doctor if you develop a fever or have an infection.

Do not have immunizations/vaccinations without talking to your doctor first. Also, avoid contact with people who recently had immunizations /vaccinations.

Canrib 150 mg Tablet 60's is not a traditional chemotherapy pill. It's a targeted therapy, also known as a PARP inhibitor, which works differently from chemotherapy.

When taking Canrib 150 mg Tablet 60's, avoid or limit foods high in grapefruit or grapefruit juice, as these can interact with the medication. Additionally, consult your doctor or pharmacist for personalized dietary advice.

The duration of Canrib 150 mg Tablet 60's treatment can vary depending on the type of cancer being treated and the patient's response to the medication. Generally, Canrib 150 mg Tablet 60's is taken until disease progression, unacceptable toxicity, or completion of a specified treatment period. Therefore, follow your doctor's instructions carefully.

Before taking Canrib 150 mg Tablet 60's, inform your doctor about all your medical conditions, sensitivities, and medications. Also, mention if you're pregnant, planning to become pregnant, or breastfeeding. This will ensure safe use and help avoid any potential interactions.

Canrib 150 mg Tablet 60's can interact with other medications, so do not use any other medications unless your doctor advises. Your doctor will check for potential interactions and advise you on how to take them safely with Canrib 150 mg Tablet 60's.

No, Canrib 150 mg Tablet 60's is not recommended for use during pregnancy and breastfeeding, and it causes unwanted side effects. However, please consult your doctor if you have any concerns.

The common side effects of Canrib 150 mg Tablet 60's are feeling very tired, pale skin, feeling sick (nausea), being sick (vomiting), indigestion or heartburn (dyspepsia), loss of appetite, headache, changes in taste of foods (dysgeusia), feeling dizzy, cough and diarrhoea. Please consult your doctor if any of these side effects persist or worsen.